To escalate thromboprophylacic heparin intensity in COVID-19 or not? That is still the question.

Bikdeli, Behnood

Bikdeli, Behnood.

Bikdeli B; Cardiovascular Medicine Division Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.

Res Pract Thromb Haemost ; 6(4): e12738, 2022 May.

Article in English | MEDLINE | ID: covidwho-1866566

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148841
https://dx.doi.org/10.1002/rth2.12738

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Res Pract Thromb Haemost Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148841
https://dx.doi.org/10.1002/rth2.12738

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Res Pract Thromb Haemost Year: 2022 Document Type: Article